Implantable Loop Recorders Market to be driven by the Growing incidence of cardiovascular disorders is expected to drive market expansion shortly at a CAGR of 8.00% during the forecast period 2024 to 2032

Market Research Future (MRFR) has published a cooked research report on the “Implantable Loop Recorders Market” that contains information from 2019 to 2032. The Implantable Loop Recorders Market is estimated to register a CAGR of 8.00% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Implantable Loop Recorders Market— Medtronic plc, Biotronik AG, Abbott Laboratories, Angel Medical Systems, Inc., Boston Scientific Corporation, and Victorious.

Implantable Loop Recorders Market Highlights

The global Implantable Loop Recorders Market is accounted to register a CAGR of 8.00% during the forecast period and is estimated to reach USD 2.77 billion by 2032

Some of the reasons driving the market expansion include the rising prevalence of cardiovascular diseases, technological developments, and the expanding need for remote patient monitoring. The chance of acquiring chronic heart problems is further increased by physical inactivity brought on by a sedentary lifestyle, which is anticipated to fuel market expansion.

Segment Analysis

The global Implantable Loop Recorders Market has been segmented based on the Product, Indication, and End-User.

Based on the Product, the market is segmented into Manual and Automatic. The automatic segment was attributed to holding the largest market share in 2023. Automatic recorders automatically replace diagnosis accuracy by detecting abnormal electrical activity of the heart tissue, and this can be done over an extended period. This approach can detect abnormal electrical activity even when it happens in long intervals, and this may go unnoticed by conventional monitoring methods. These devices were able to record and capture the data of a patient's cardiac rhythms and hence provided the doctors with the complete details of the person's cardiac health patterns. This will assist in proper diagnosis and treatment planning.

Based on the Indication, the Implantable Loop Recorders Market has been segmented into Cardiovascular Syncope, Stroke, Heart Failure, Cardiac Arrhythmia, Atrial Fibrillation, Bundle Branch Block, and Others. The atrial fibrillation segment was expected to hold the largest market share in 2023. ANHS (NIH) reported that 7.13 crores of people are affected worldwide by the AF, i.e., 0.51% of the total population; the prevalence has roughly doubled in the last 20 years with an increasing rate of 33%. The loop recorders have had a great impact on the long-term monitoring of the electrocardiogram as well as the post-stroke diagnosis of cryptogenic atrial fibrillation. For those who suffer from AF, the formation of a blood clot in the heart and stroke by almost five times increased the risk compared with the others.

Based on the End-User, the Implantable Loop Recorders Market has been segmented into Hospitals, Cardiac Centers & Clinics, and Ambulatory Surgical Centers. The hospitals segment was expected to hold the largest market share in 2023. The increasing volume rate of MIS (Minimally Invasive Surgeries) in hospitals is one of the contributing factors to the growth of the segment. In addition, implemented reimbursement regulations must also be regarded as a significant cause of the surge in demand for implantable loop recorders. High rates of less-invasive surgeries are also accompanied by the quick rise of the market.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Implantable Loop Recorders Market Research Report

Regional Analysis

The global Implantable Loop Recorders Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Implantable Loop Recorders Market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The Implantable Loop Recorders Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Implantable Loop Recorders Market comprises the Middle East, Africa, and Latin America.

The largest market share for the Implantable Loop Recorders Market was maintained by the North American regional sector. The increasing load of cardiovascular diseases, including cardiac arrhythmias, hypertension, and others among the population, will potentially give rise to the demand for implantable loop recorders, measuring and detecting irregular heart rhythms and other purposes. For example, according to the American Heart Association, in June 2021, the prevalence rate of brain failure in Canada was between 1.5% to 1.9%. This leads to a situation where a bigger number of cases of heart failure in the community increases the possibility of AF (atrial fibrillation), which needs checking on the heart rhythm regularly and consequently is expected to raise demand for an implantable loop recorder over the projection period.

Moreover, the Europe market has been persistently growing over the forecast period. The cardiac rhythm disorder, comprising atrial fibrillation (AF) and bradycardia, is widespread in Europe, especially among the elderly. Statistical data for the usual death rate caused by cerebrovascular accidents in the year 2020 showed a gap of 8.4 times between the EU Member State that had the highest rate (Bulgaria) and that that had the lowest rate (France). By the year 2021 in Germany, around 37,200 coronary artery bypasses were performed; this number was more than double that of any of the remaining EU Member States’ volume (in France, 17,400 operations were done). The ILRs serve an important purpose in the early identification and follow-up of these diseases as they accurately monitor the natural behavior of the heart over long periods through the continuous recording of the electrical activity in the heart. With the broadening of arrhythmias promoted and screenings expanded, the need for ILRs will escalate.

In Asia Pacific, the expansion can be attributed to advanced cardiac management technologies made by the APSC and the China Cardiovascular Association. Moreover, meal patterns and sedentary lifestyle adherence, which favors physical inactivity, serve to deepen cardiovascular diseases in the region. About one-third of total deaths recorded in Asia in 2019 were caused by cardiovascular issues, where at least nearly 11 million lives in Asia could have disappeared due to cardiovascular diseases. As per the 'Accidental Deaths & Suicides in India' report, in the course of the last four years, the dynamism within the range of heart failure deaths was from 25,000 to 28,000, according to the research in 2022. These factors are also pushing up the necessity of implantable loop recorders in the market.

Furthermore, the rest of the world's Implantable Loop Recorders Market is divided into the Middle East, Africa, and Latin America. Regions are seeing an increase in cardiovascular diseases, especially rhythm disorders like atrial fibrillation. According to the Latin American epidemiological data for 2019, cardiovascular diseases were the cause of 1.09 million deaths (38% of all the deaths from non-communicable diseases), transmitted from one generation to another. The magnitude of the fatalities and the subsequent economic consequences of the disease are estimated to worsen and reach $30.9 billion by 2015. ILRs are suitable for checking and recognizing illnesses that are activated by the heart's electrical activity, as they make continuous records during an extended period.

Key Findings of the Study

• The global Implantable Loop recorder market is expected to reach USD 2.77 billion by 2032, at a CAGR of 8.00% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market because of the growing awareness about the benefits of several cardiac monitoring devices and the increasing disposable income in the region.


• Based on Product, the Automatic segment was attributed to holding the largest market in 2023.


• Medtronic plc, Biotronik AG, Abbott Laboratories, Angel Medical Systems, Inc., Boston Scientific Corporation, and Vectorious are the key market players.